Study Evaluating Approach to Treatment of Haemophilia A and B in Spain

Study Evaluating Inhibitor Specificity in Hemophilia A

NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4

Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and Inhibitors

NCT02018393 ·Status: UNKNOWN

Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia

NCT07099313 ·Status: RECRUITING

Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia

NCT03914209 ·Status: UNKNOWN

Treatment of Hemophilia A Patients With FVIII Inhibitors

NCT04023019 ·Status: RECRUITING

Transcultural Multidisciplinary Evaluation of Patients With Hemophili

NCT02199639 ·Status: UNKNOWN

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

NCT03695978 ·Status: RECRUITING

Clinical and Health-related Outcome of rFVIIIFc Prophylaxis

NCT04583930 ·Status: UNKNOWN

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

NCT03741881 ·Status: COMPLETED

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301 ·Status: COMPLETED

Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients

NCT02540187 ·Status: COMPLETED

Multidisciplinary Evaluation of Patients With Hemophilia

NCT02198430 ·Status: COMPLETED

Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients

NCT03179748 ·Status: COMPLETED

Epidemiology and Immunology of Hemophilia A Inhibitors

NCT00005518 ·Status: COMPLETED

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

NCT00782470 ·Status: COMPLETED

A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A

NCT06461533 ·Status: RECRUITING

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

NCT01561391 ·Status: COMPLETED ·Phase: PHASE4

A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

NCT05662319 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

NCT01125813 ·Status: COMPLETED ·Phase: PHASE3

Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors

NCT02453542 ·Status: RECRUITING

Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

NCT00213473 ·Status: COMPLETED

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

NCT01913405 ·Status: COMPLETED ·Phase: PHASE3

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

NCT01288391 ·Status: COMPLETED ·Phase: PHASE1

Emicizumab in Acquired Hemophilia A

NCT04188639 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

NCT04165135 ·Status: COMPLETED